If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJpel Priv Eqty Regulatory News (JPEL)

Share Price Information for Jpel Priv Eqty (JPEL)

Share Price is delayed by 15 minutes
Get Live Data
1.24    0.00 (0.00%)
Bid:
1.20
Ask:
1.28
Spread: 0.08 (6.667%)
Market Cap: $21.21m
JPEL Live PriceLast checked at - London Stock Exchange

Intraday Jpel Priv Eqty Share Chart

Issue of Equity

17 Nov 2009 17:14

RNS Number : 6626C
J.P. Morgan Private Equity Ltd
17 November 2009
Β 

ο»Ώ

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTOΒ AUSTRALIA,Β CANADA,Β JAPANΒ OR THE UNITED STATES OFΒ AMERICAΒ OR TO US PERSONS

FOR IMMEDIATE RELEASEΒ 

J.P. MORGAN PRIVATE EQUITY LIMITEDΒ -Β ISSUE OF SHARESΒ 

17 November 2009

This announcement appears as a matter of record only.Β 

J.P. Morgan Private Equity Limited ("JPEL"Β or the "Company") is pleased to announce theΒ successfulΒ completion of itsΒ offeringΒ ofΒ 2015Β zero dividend preference sharesΒ (the "2015 ZDP Shares"). As the offering was oversubscribed, the Company has closed on its maximum target of Β£30,000,000.

The CompanyΒ resolvedΒ to issue anΒ aggregateΒ of 53,333,333Β 2015 ZDP Shares at a price of 56.25p per share, representing a 7.46 per cent gross redemption yieldΒ to investors.

The issue represented the maximum number of shares offered under the prospectus published by the Company onΒ 10 November 2009. As such, the Company's board of directors has indicated that JPELΒ does not intendΒ to issue any additional 2015 ZDP Shares in the foreseeable future as a result of the successful placement.

TheΒ issuance of the 2015 ZDP SharesΒ is conditional, inter alia, on admission of theΒ 2015 ZDP SharesΒ to the Official List of the UK Listing Authority and to trading on the London Stock Exchange's market for listed securities ("Admission").Β Application has been made forΒ 53,333,333Β 2015 ZDP Shares to be admitted to the Official List of the UK Listing Authority and to trading on the London Stock Exchange. It is expected that Admission will become effective, settlement will occur and dealings in theΒ 2015 ZDP SharesΒ will commence onΒ 20 November 2009.Β 

EXPECTED TIMETABLE

2009

(LondonΒ time)

Admission to listing of theΒ 2015Β ZDPΒ Shares

8.00 a.m.Β onΒ 20Β November

Dealings in theΒ 2015Β ZDPΒ Shares to commence on the London Stock Exchange

8.00 a.m.Β onΒ 20 November

CREST (stock) accounts credited

20 November

Certificates despatched for theΒ 2015Β ZDPΒ Shares

week commencingΒ 23 November

The times and dates set out in the expected timetable of events above and mentioned throughout this document may be adjusted by the Company, in which event the Company will notify investors of changes to the timetable by publication of a notice through a RIS provider.

All references in this document to time are toΒ LondonΒ time.

Defined terms used in this announcement shall have the meaning assigned to them in the prospectusΒ issued by the Company onΒ 10Β NovemberΒ 2009Β unless expressly stated otherwise.

Enquiries:Β 

Β 

J.P. MorganΒ Asset ManagementΒ 

Troy DuncanΒ /Β Greg GetschowΒ 

+Β 44 (0) 20 7247 3032 / +1 212Β 648Β 1150

Cenkos Securities plc

Peter HindmarshΒ / Will RogersΒ 

+ 44 (0) 7397Β 8900

J.P.Β MorganΒ CazenoveΒ 

Angus GordonΒ LennoxΒ / Edward Gibson-Watt

+44 (0) 020 7588 2828Β 

Β 

Anthony Payne / Max Hilton +44 (0) 20Β 31786869Β 

anthony.payne@peregrinecommunications.co.ukΒ 

Β 

DISCLAIMER

THIS ANNOUNCEMENTΒ HASΒ BEEN ISSUED BY,Β ANDΒ IS THE SOLE RESPONSIBILITY OFΒ J.P.Β MORGANΒ PRIVATE EQUITY LIMITED.Β 

This announcement does not constitute orΒ formΒ part of an offer to sell, purchase, exchange or subscribe for any securities or solicitation of such an offer in the United States of America or any other jurisdiction. The CompanyΒ hasΒ not beenΒ andΒ will not be registered under the United States Investment Company Act of 1940,Β as amended.Β The securities referred to in this announcement have not beenΒ andΒ will not be registered under the United States Securities Act 1933, as amended,Β andΒ will not be offeredΒ or sold or otherwise transferred within the Unites States or to, or for the account or benefit of US Persons (as defined in Regulations of the Securities Act of 1933 as amended) except in accordance with the United States Securities Act of 1933, asΒ amended, or an exemption therefromΒ andΒ under the circumstances which will not require the company to register under the United States Investment Act of 1940, as amended.

THE RELEASE, PUBLICATION OR DISTRIBUTION OF THIS ANNOUNCEMENT INTO CERTAIN JURISDICTIONS OTHERΒ THANΒ THEΒ UKΒ MAYΒ BE RESTRICTED BY LAWΒ ANDΒ THEREFORE PERSONS IN SUCH JURISDICTIONS INTO WHICH THIS ANNOUNCEMENT IS RELEASED, PUBLISHED OR DISTRIBUTED SHOULD INFORM THEMSELVES ABOUTΒ ANDΒ OBSERVE ANY SUCH RESTRICTIONS.Β NO ACTIONΒ HASΒ BEEN TAKEN BY THE COMPANY OR JPMC THAT WOULD PERMIT AN OFFERING OF SUCH SHARES OR POSSESSION OR DISTRIBUTION OF THIS ANNOUNCEMENT OR ANY OTHER OFFERING OR PUBLICITY MATERIAL RELATING TO SUCH SHARES IN ANY JURISDICTION WHERE ACTION FOR THAT PURPOSE IS REQUIRED.Β ANY FAILURE TO COMPLY WITH ANY SUCH RESTRICTIONSΒ MAYΒ CONSTITUTE A VIOLATION OF THE SECURITIESΒ LAWSΒ OR REGULATION OF SUCH JURISDICTIONS.Β 

THIS ANNOUNCEMENT INCLUDES FORWARD-LOOKING STATEMENTS THATΒ AREΒ PREDICTIONS OF OR INDICATE FUTURE EVENTSΒ ANDΒ FUTUREΒ TRENDS. THESE FORWARD-LOOKING STATEMENTS INCLUDEΒ ALLΒ MATTERS THATΒ AREΒ NOT HISTORICAL FACTS. UNDUE RELIANCE SHOULD NOT BE PLACED ON FORWARD-LOOKING STATEMENTS BECAUSE THEY INVOLVE KNOWNΒ ANDΒ UNKNOWN RISKS, UNCERTAINTIESΒ ANDΒ OTHER FACTORS THATΒ AREΒ IN MANY CASES BEYOND THE COMPANY'S CONTROL. BY THEIR NATURE, FORWARD-LOOKING STATEMENTS INVOLVE RISKSΒ ANDΒ UNCERTAINTIES BECAUSE THEY RELATE TO EVENTSΒ ANDΒ DEPEND ON CIRCUMSTANCES THATΒ MAYΒ ORΒ MAYΒ NOT OCCUR IN THE FUTURE.Β 

FORWARD-LOOKING STATEMENTSΒ AREΒ NOT GUARANTEES OF FUTURE PERFORMANCE,Β ANDΒ THE COMPANY'S ACTUAL RESULTS OF OPERATIONS, FINANCIAL CONDITIONΒ ANDΒ LIQUIDITY,Β ANDΒ THE DEVELOPMENT OF THE INDUSTRY IN WHICH IT OPERATESΒ MAYΒ DIFFER MATERIALLY FROM THOSE MADE IN OR SUGGESTED BY THE FORWARD-LOOKING STATEMENTS CONTAINED IN THIS ANNOUNCEMENT. THE CAUTIONARY STATEMENTS SETΒ FORTHΒ ABOVE SHOULD BE CONSIDERED IN CONNECTION WITH ANY SUBSEQUENT WRITTEN OR ORAL FORWARD-LOOKING STATEMENTS THAT THE COMPANY, OR PERSONS ACTING ON ITS BEHALF,Β MAYΒ ISSUE. THESE FORWARD-LOOKING STATEMENTSΒ AREΒ MADE AS OF THE DATE OF THIS ANNOUNCEMENTΒ ANDΒ AREΒ NOT INTENDED TO GIVE ANY ASSURANCES AS TO FUTURE RESULTS. SAVE AS REQUIRED BY LAW OR REGULATION, THE COMPANY UNDERTAKES NO OBLIGATION TO UPDATE THESE FORWARD-LOOKING STATEMENTS,Β ANDΒ WILL NOT PUBLICLY RELEASE ANY REVISIONS ITΒ MAYΒ MAKE TO THESE FORWARD-LOOKING STATEMENTS THATΒ MAYΒ RESULT FROM EVENTS OR CIRCUMSTANCESΒ 

ARISING AFTER THE DATE OF THIS ANNOUNCEMENT.Β 

JPMC, which is authorisedΒ andΒ regulated in the United Kingdom by the Financial Services Authority, is acting for the CompanyΒ andΒ for noΒ oneΒ elseΒ in connection with the matters referred to in this announcementΒ andΒ will not be responsible to anyone otherΒ thanΒ the Company for providing the protections afforded to clients ofΒ JPMCΒ or for affording advice in relation to the contents of this announcement or on any matters referred to herein.Β 

This announcement is not for distribution directly or indirectly in or into the UnitedΒ States,Β Canada,Β AustraliaΒ orΒ Japan. No public offering of securities will be made in the UnitedΒ States,Β Canada,Β Australia, orΒ Japan.Β 

This Announcement is only addressed toΒ andΒ directed at persons in member states of the European Economic Area whoΒ areΒ "qualified investors" ("Qualified Investors") within the meaning of Article 2(1)(e) of the EU Prospectus Directive (Directive 2003/71/EC) (the "Prospectus Directive"). Any person in the EEA who acquires any securities in the Placing or to whom any offer of securities is made will be deemed to have acknowledgedΒ andΒ agreed that theyΒ areΒ such a Qualified Investor.

In the case of any securities acquired by a financial intermediary as that term is used in Article 3(2) of the Prospectus Directive, such financial intermediary will also be deemed to have representedΒ andΒ warranted that the securities acquired by it in the Placing have not been acquired on a non-discretionary basis on behalf of,Β norΒ have they have been acquired with a view to their offer or resale to, persons in circumstances whichΒ mayΒ give rise to an offer of securities to the public otherΒ thanΒ an offer or resale in a member state of the EEA whichΒ hasΒ implemented the Prospectus Directive to Qualified Investors or in circumstances in which the prior consent of JPMCΒ hasΒ been given to each such proposed offer or resale.

This AnnouncementΒ hasΒ been issued byΒ andΒ is the sole responsibility of the Company. No representation or warranty express or implied, is or will be made as to,Β andΒ no responsibility or liability is or will be accepted by JPMC or by any of its affiliates or agents as to or in relation to, the accuracy or completeness of this Announcement or any other written orΒ oralΒ information made available to or publicly available to any interested party or its advisers,Β andΒ any liability therefore is expressly disclaimed.

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
ROICKOKDOBDDNDD
Date   Source Headline
2nd Jun 20269:29 amRNSNet Asset Value - March 2026
23rd Apr 20267:00 amRNSJoint Broker Appointment
14th Apr 20267:00 amRNSAppointment of Directors
6th Mar 20265:59 pmRNSHalf-year Financial Report - December 2025
14th Jan 20269:53 amRNSCOMPLETION OF THIRTEENTH MANDATORY REDEMPTION
29th Dec 20253:18 pmRNSTHIRTEENTH MANDATORY REDEMPTION
19th Dec 20255:53 pmRNSNet Asset Value September 2025
2nd Dec 20254:44 pmRNS2025 AGM Results Statement
10th Nov 202512:19 pmRNS2025 AGM Circular Statement
5th Nov 20254:07 pmRNSHolding(s) in Company
3rd Nov 20254:30 pmRNSHolding(s) in Company
3rd Nov 20254:11 pmRNSHolding(s) in Company
30th Oct 20257:00 amRNSAnnual Financial Report 2025
22nd Jul 20257:00 amRNSAppointed Sole Corp. Broker & Financial Adviser
10th Jun 20254:47 pmRNSNet Asset Value - March 2025
1st May 20256:11 pmRNSHolding(s) in Company
18th Mar 20255:04 pmRNSHalf-year Report - December 2024
3rd Dec 20242:30 pmRNSNet Asset Value September 2024
27th Nov 20245:16 pmRNS2024 AGM Results
6th Nov 20247:00 amRNS2024 AGM Circular
25th Oct 20247:00 amRNSPortfolio Update
25th Oct 20247:00 amRNSAnnual Financial Report - 2024
5th Jun 20247:00 amRNSNet Asset Value - March 2024
23rd Apr 20245:18 pmRNSDirector Declaration
15th Mar 20246:15 pmRNSNet Asset Value - December 2023
15th Mar 20246:03 pmRNSHalf-year Report - December 2023
15th Mar 20243:50 pmRNSHalf-year Report - 2023
6th Dec 20235:36 pmRNSDirector Declaration
6th Dec 20235:33 pmRNSAGM RESULTS 2023
9th Nov 202311:56 amRNS2023 AGM CIRCULAR
8th Nov 20237:00 amRNSCompletion of Twelfth Mandatory Redemption
24th Oct 20237:00 amRNSTwelfth Mandatory Redemption & Shareholder Update
20th Oct 202310:28 amRNSNet Asset Value - September 2023
21st Sep 20235:33 pmRNSNet Asset Value(s) - June 2023
21st Jun 20233:36 pmRNSDirectorate Change
12th May 20231:46 pmRNSNet Asset Value(s) - March 2023
28th Mar 20233:32 pmRNSHalf-year Report - 31 December 2022
14th Mar 20234:35 pmRNSPrice Monitoring Extension
14th Mar 20232:05 pmRNSSecond Price Monitoring Extn
14th Mar 20232:00 pmRNSPrice Monitoring Extension
14th Mar 202311:05 amRNSSecond Price Monitoring Extn
14th Mar 202311:00 amRNSPrice Monitoring Extension
14th Mar 20239:05 amRNSSecond Price Monitoring Extn
14th Mar 20239:00 amRNSPrice Monitoring Extension
24th Feb 20234:22 pmRNSNet Asset Value(s) - December 2022
13th Feb 20234:51 pmRNSDirector Declaration
22nd Dec 20227:00 amRNSCompletion of Eleventh Mandatory Redemption
14th Dec 20227:00 amRNSELEVENTH MANDATORY REDEMPTION & SHAREHOLDER UPDATE
13th Dec 20225:09 pmRNSDirectorate Change
29th Nov 20224:33 pmRNSAGM Results 2022

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.